Literature DB >> 21205953

Physician perceptions about generic drugs.

William H Shrank1, Joshua N Liberman, Michael A Fischer, Charmaine Girdish, Troyen A Brennan, Niteesh K Choudhry.   

Abstract

BACKGROUND: With constrained health-care resources, there is a need to understand barriers to cost-effective medication use.
OBJECTIVE: To study physician perceptions about generic medications.
METHODS: Physicians used 5-point Likert scales to report perceptions about cost-related medication nonadherence, the efficacy and quality of generic medications, preferences for generic use, and the implications of dispensing medication samples. Descriptive statistics were used to assess physician perceptions and logistic regression models were used to evaluate predictors of physician perceptions.
RESULTS: Among the invited sample, 839 (30.4%) responded and 506 (18.3%) were eligible and included in the final study population. Over 23% of physicians surveyed expressed negative perceptions about efficacy of generic drugs, almost 50% reported negative perceptions about quality of generic medications, and more than one quarter do not prefer to use generics as first-line medications for themselves or for their family. Physicians over the age of 55 years were 3.3 times more likely to report negative perceptions about generic quality, 5.8 times more likely to report that they would not use generics themselves, and 7.5 times more likely to state that they would not recommend generics for family members (p < 0.05 for all). Physicians reported that pharmaceutical company representatives are the most common (75%) source of information about market entry of a generic medication. Almost half of the respondents expressed concern that free samples may adversely affect subsequent affordability, yet two thirds of respondents provide free samples.
CONCLUSIONS: A meaningful proportion of physicians expressed negative perceptions about generic medications, representing a potential barrier to generic use. Payors and policymakers trying to encourage generic use may consider educational campaigns targeting older physicians.

Mesh:

Substances:

Year:  2011        PMID: 21205953     DOI: 10.1345/aph.1P389

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  54 in total

1.  The diffusion of generics after patent expiry in Germany.

Authors:  Katharina Elisabeth Fischer; Tom Stargardt
Journal:  Eur J Health Econ       Date:  2015-11-16

2.  Factors affecting the opinions of family physicians regarding generic drugs--a questionnaire based study.

Authors:  Pawel Lewek; Janusz Smigielski; Przemyslaw Kardas
Journal:  Bosn J Basic Med Sci       Date:  2014-12-17       Impact factor: 3.363

3.  Product-Specific Regulatory Pathways to Approve Generic Drugs: The Need for Follow-up Studies to Ensure Safety and Effectiveness.

Authors:  Aaron S Kesselheim; Joshua J Gagne
Journal:  Drug Saf       Date:  2015-10       Impact factor: 5.606

4.  The economic impact of the transition from branded to generic oncology drugs.

Authors:  W Y Cheung; E A Kornelsen; N Mittmann; N B Leighl; M Cheung; K K Chan; P A Bradbury; R C H Ng; B E Chen; K Ding; J L Pater; D Tu; A E Hay
Journal:  Curr Oncol       Date:  2019-04-01       Impact factor: 3.677

Review 5.  Access to cancer medications in low- and middle-income countries.

Authors:  Gilberto de Lima Lopes; Jonas A de Souza; Carlos Barrios
Journal:  Nat Rev Clin Oncol       Date:  2013-04-09       Impact factor: 66.675

6.  Disclosure of industry payments to prescribers: industry payments might be a factor impacting generic drug prescribing.

Authors:  Jingjing Qian; Richard A Hansen; Daniel Surry; Jennifer Howard; Zippora Kiptanui; Ilene Harris
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-05-09       Impact factor: 2.890

7.  In vitro Comparison of Generic and Branded Preparations of Amoxicillin with Potassium Clavulanate.

Authors:  Priyanka Pathak; Jayshree Dawane
Journal:  J Clin Diagn Res       Date:  2016-09-01

8.  Perception of generic prescription drugs and utilization of generic drug discount programs.

Authors:  Anthony Omojasola; Mike Hernandez; Sujit Sansgiry; Lovell Jones
Journal:  Ethn Dis       Date:  2012       Impact factor: 1.847

Review 9.  Influencers of generic drug utilization: A systematic review.

Authors:  Jennifer N Howard; Ilene Harris; Gavriella Frank; Zippora Kiptanui; Jingjing Qian; Richard Hansen
Journal:  Res Social Adm Pharm       Date:  2017-08-04

10.  A drug utilization study of psychotropic drugs prescribed in the psychiatry outpatient department of a tertiary care hospital.

Authors:  Karan B Thakkar; Mangal M Jain; Gauri Billa; Abhijit Joshi; Akash A Khobragade
Journal:  J Clin Diagn Res       Date:  2013-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.